Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study on the Newly Developed Early Intervention for Families of Patients With Acquired Brain Injuries: SAFIR©

NCT04138524 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Vaudois as lead sponsor.

NCT NCT04138524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04138524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study on the Newly Developed Early Intervention for Families of Patients With Acquired Brain Injuries: SAFIR©
Lead sponsor
Centre Hospitalier Universitaire Vaudois
Phase
Not applicable
Overall status
Terminated
Start date
November 21, 2019
Completion date
June 30, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired brain injury